These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 28798289)
1. Prolonged Administration of Twice-Daily Bolus Intravenous Tacrolimus in the Early Phase After Lung Transplantation. Hirano Y; Sugimoto S; Mano T; Kurosaki T; Miyoshi K; Otani S; Yamane M; Kobayashi M; Miyoshi S; Oto T Ann Transplant; 2017 Aug; 22():484-492. PubMed ID: 28798289 [TBL] [Abstract][Full Text] [Related]
2. Evolution to twice daily bolus intravenous tacrolimus: optimizing efficacy and safety of calcineurin inhibitor delivery early post lung transplant. Snell GI; Ivulich S; Mitchell L; Westall GP; Levvey BJ Ann Transplant; 2013 Aug; 18():399-407. PubMed ID: 23921892 [TBL] [Abstract][Full Text] [Related]
4. Twice daily i.v. bolus tacrolimus infusion for GVHD prophylaxis in children undergoing stem cell transplantation. Skeens M; Pai V; Garee A; Termuhlen AM; Bajwa RP; Gross TG; Soni S Bone Marrow Transplant; 2012 Nov; 47(11):1415-8. PubMed ID: 22484323 [TBL] [Abstract][Full Text] [Related]
5. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient. Montini G; Murer L; Ghio L; Pietrobon B; Ginevri F; Ferraresso M; Cardillo M; Scalamogna M; Perfumo F; Edefonti A; Zanon GF; Zacchello G Transpl Int; 2005 Jan; 18(1):36-42. PubMed ID: 15612981 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage. Liu CL; Fan ST; Lo CM; Chan SC; Ng IO; Lai CL; Wong J Liver Transpl; 2004 Jun; 10(6):728-33. PubMed ID: 15162466 [TBL] [Abstract][Full Text] [Related]
7. An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients. Bhatia M; Militano O; Jin Z; Figurski M; Shaw L; Moore V; Morris E; Tallamy B; van deVen C; Ayello J; Baxter-Lowe L; Satwani P; George D; Bradley MB; Garvin J; Cairo MS Biol Blood Marrow Transplant; 2010 Mar; 16(3):333-43. PubMed ID: 19835971 [TBL] [Abstract][Full Text] [Related]
8. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up. Ciancio G; Burke GW; Gaynor JJ; Roth D; Sageshima J; Kupin W; Tueros L; Hanson L; Rosen A; Ruiz P; Miller J Transplantation; 2008 Jul; 86(1):67-74. PubMed ID: 18622280 [TBL] [Abstract][Full Text] [Related]
9. Intravenous mycophenolate mofetil with low-dose oral tacrolimus and steroid induction for live donor liver transplantation. Jain A; Mohanka R; Orloff M; Abt P; Kashyap R; Kelley M; Burlee K; Bozorgzadeh A Exp Clin Transplant; 2005 Dec; 3(2):361-5. PubMed ID: 16417444 [TBL] [Abstract][Full Text] [Related]
10. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up. Greig P; Lilly L; Scudamore C; Erb S; Yoshida E; Kneteman N; Bain V; Ghent C; Marotta P; Grant D; Wall W; Tchervenkov J; Barkun J; Roy A; Marleau D; McAlister V; Peltekian K Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400 [TBL] [Abstract][Full Text] [Related]
11. Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction. Jain A; Sharma R; Ryan C; Tsoulfas G; Orloff M; Abt P; Kashyap R; Batzold P; Sauberman L; Safadjou S; Graham M; Bozorgzadeh A Liver Transpl; 2008 Feb; 14(2):202-9. PubMed ID: 18236395 [TBL] [Abstract][Full Text] [Related]
12. Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results. Chamienia A; Dębska-Ślizień A; Król E; Biedunkiewicz B; Rutkowski B Transplant Proc; 2014 Oct; 46(8):2714-8. PubMed ID: 25380901 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials. Krämer BK; Albano L; Banas B; Charpentier B; Bäckman L; Tedesco-Silva H; Lehner F; Mondragón-Ramírez GA; Glyda M; Cassuto-Viguier E; Viklický O; Mourad G; Rigotti P; Schleibner S; Kamar N Transplant Proc; 2017 Nov; 49(9):2040-2049. PubMed ID: 29149958 [TBL] [Abstract][Full Text] [Related]
15. A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation. Reggiani P; Arru M; Regazzi M; Gatti S; Molinaro MD; Caccamo L; Maggi U; Melada E; Paone G; Rossi G Transplant Proc; 2005 May; 37(4):1697-9. PubMed ID: 15919435 [TBL] [Abstract][Full Text] [Related]
16. Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen. Yang SL; Wang D; Wu WZ; Lin WH; Xu TZ; Cai JQ; Tan JM Transpl Immunol; 2008 Jan; 18(3):281-5. PubMed ID: 18047938 [TBL] [Abstract][Full Text] [Related]
17. Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial. Mourad G; Glyda M; Albano L; Viklický O; Merville P; Tydén G; Mourad M; Lõhmus A; Witzke O; Christiaans MHL; Brown MW; Undre N; Kazeem G; Kuypers DRJ; Transplantation; 2017 Aug; 101(8):1924-1934. PubMed ID: 27547871 [TBL] [Abstract][Full Text] [Related]
18. A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients. Osunkwo I; Bessmertny O; Harrison L; Cheung YK; Van de Ven C; del Toro G; Garvin J; George D; Bradley MB; Wolownik K; Wischhover C; Levy J; Skerrett D; Cairo MS Biol Blood Marrow Transplant; 2004 Apr; 10(4):246-58. PubMed ID: 15077223 [TBL] [Abstract][Full Text] [Related]
19. Combination therapy with tacrolimus and mycophenolate mofetil: effects of early and late minimization of mycophenolate mofetil after renal transplant. Walker R; Thomas M; Goodman D; Campbell S; Chadban S; Clin Transplant; 2008; 22(5):594-602. PubMed ID: 18459999 [TBL] [Abstract][Full Text] [Related]
20. Safe One-to-One Dosage Conversion From Twice-Daily to Once-Daily Tacrolimus in Long-Term Stable Recipients After Liver Transplantation. Wu YJ; Lin YH; Yong CC; Li WF; Wang SH; Wang CC; Lin TL; Chen CL; Lin CC Ann Transplant; 2016 Jan; 21():30-4. PubMed ID: 26782179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]